Positron-emitting isotopes suitable for studying the following aspects of cancer drug delivery
Positron emission tomography (PET) imaging uses radiotracers that can reveal both anatomical and metabolic information. The glucose analog, 2-[fluorine-18]-fluoro-2-deoxy-D-glucose (FDG), is possibly helpful in cancerous infection imaging because tumor units display expanded utilization of glucose. This expertise evaluation reconsiders clues on the use of FDG PET imaging in breast cancerous infection and focuses on 4 exact clinical settings:
Initial diagnosis of breast cancer
Staging axillary lymph nodes
Detection of locoregional recurrence or distant metastasis/recurrence